Close
What would you like to look for?
Site search
31 January 2020

Resistell AG has closed a milestone-based CHF 3.5M Series A Financing round led by OCCIDENT. TRUMPF Venture, Alpana Ventures, Zürcher Kantonalbank, HEMEX and seven private investors also back the start-up developing world’s fastest phenotypic antibiotic susceptibility test. VISCHER AG (Matthias Staehelin and Livia Pedrojetta, both Corporate) is advising Resistell AG.

Press release

Author